Hangzhou Jiuyuan Gene (2566.HK)

Hangzhou Jiuyuan Gene Engineering Co., Ltd. engages in the research, development, production and sales of biopharmaceutical products and medical devices. It offers Guyoudao, a recombinant human bone morphogenetic protein-2 (rhBMP-2) bone repair product; Jilifen, a Human granulocyte colony stimulating factor injection for neutropenia; and Jijufen, a human interleukin-11 injection for chemotherapy-induced thrombocytopenia. The company also provides Jitansu, a fosaprepitant dimeglumine injection for chemotherapy-induced nausea and vomiting; Jifuwei, a fulvestrant injection for advanced breast cancer; Yirojia, an enoxaparin sodium injection for Venous thromboembolic diseases; Jipalin, a low molecular weight heparin sodium injection for Venous thromboembolic diseases; and Jiouting, a palonosetron hydrochloride injection for nausea and vomiting induced by radiation therapy, chemotherapy or postoperatively. It offers its products in the areas of orthopedics, metabolic diseases, oncology, and hematology. The company was incorporated in 1993 and is based in Hangzhou, China. Show more